疫苗接种程序变更是否影响德国早产与足月婴儿肺炎球菌结合疫苗接种的依从性与完成率?来自理赔数据库分析的答案
基于德国理赔数据库的回顾性分析,评估2015年8月STIKO将足月婴儿PCV程序从3+1改为2+1、早产儿仍为3+1后,2013、2016、2018年出生婴儿24月龄内PCV接种率、完整性与及时性。结果显示2018年早产儿仅47%、足月儿74%获得推荐剂次,未接种率仍较高且接种常延迟,无证据表明减少剂次提高足月儿接种接受度。
要点
- 2018年早产儿仅47%完成推荐PCV剂次,足月儿为74%。
- 全程六价联合疫苗3+1剂次接种率随时间稳定上升。
- 约50%早产与足月婴儿按推荐时间接种加强剂。
核心结论
- 无证据表明足月婴儿减少PCV剂次提高了疫苗接种接受度。
- 未接种婴儿比例仍处于较高水平且接种常延迟。
- 尽管STIKO仍推荐早产儿3+1 PCV程序,不足半数儿童完成全程接种。
- 需努力提高对STIKO推荐的依从性,尤其针对早产儿这一脆弱群体。
研究设计与样本
- 回顾性理赔数据分析,使用综合研究数据库。
- 研究对象为2013、2016或2018年出生的所有足月与早产婴儿,个体随访24个月。
- 早产儿依据ICD-10-GM编码P07.2和P07.3识别。
- 以六价联合疫苗(HEXA)3+1程序作为参照进行分析。
主要发现
- 随访24个月后,自STIKO推荐变更以来,接受至少1剂PCV和HEXA疫苗的早产与足月婴儿比例稳步上升。
- 2018年(2016/2013年)早产儿仅47%(41%/65%)获得推荐的3+1 PCV剂次,足月儿74%(72%/68%)获得推荐的2+1 PCV剂次。
- 同期六价联合疫苗3+1全程接种率在早产儿(2013/2016/2018年:66%/68%/70%)与足月儿(2013/2016/2018年:69%/72%/73%)中持续上升。
- PCV与HEXA加强剂接种及时性保持稳定,约50%的早产与足月婴儿按推荐时间接种加强剂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In August 2015, the German Standing Committee on Vaccination (STIKO) changed the pneumococcal conjugate vaccination (PCV) schedule for mature infants from a 3+1 to a 2+1scheme. For premature infants, the 3+1schedule remained unchanged. Aim was to assess vaccination rates, completeness, and timeliness for PCV stratified by premature and mature infants before and after the recommendation change based on real-world data. METHODS: Retrospective claims data analyses were conducted using a comprehensive research database. The study population consisted of all mature and premature infants born in 2013, 2016, or 2018 with an individual follow-up of 24 months using ICD-10-GM codes P07.2 and P07.3 for premature infants. Hexavalent (HEXA) combination vaccination with a consistent 3+1recommendation for premature and mature infants was analyzed as a reference. RESULTS: After follow-up of 24 months, rates of premature and mature infants receiving ≥1PCV and HEXA vaccination steadily increased since the change of STIKO's recommendation. However, in 2018 (2016/2013), only 47 % (41 %/65 %) of premature but 74 % (72 %/68 %) of mature infants obtained the recommended 3+1 respectively 2+1 PCV doses. At the same age, a consistent increase in complete HEXA vaccination with 3+1 doses was observed over time in premature (2013/2016/2018: 66 %/68 %/70 %) and mature (2013/2016/2018: 69 %/72 %/73 %) infants. Timeliness of PCV and HEXA booster administration remained stable with ∼50 % of all premature and mature infants receiving the booster according to recommended timelines. CONCLUSION: There is no proven evidence that the reduced PCV schedule for mature infants induced a higher acceptance of vaccination. The rate of unvaccinated infants remained at a considerable level and vaccinations were often delayed. Although the STIKO still recommends a 3+1 PCV schedule for premature infants in Germany, less than half of children showed a completed vaccination series. To protect these vulnerable groups, efforts are needed to increase adherence to the STIKO recommendation especially for premature infants.
引用
- Schley K, Borchert K, Seidel K, et al. Did the change of the vaccination schedule effect pneumococcal conjugate vaccination compliance and adherence of premature and mature born infants in Germany? Answers from a claims database analysis. Vaccine. 2023. PMID: 37263871. doi:10.1016/j.vaccine.2023.05.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。